Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05280340
PHASE1/PHASE2
Anakinra for Preterm Infants Pilot
Sponsor: Monash Medical Centre
View on ClinicalTrials.gov
Summary
Phase I/II study of anakinra to prevent the impact of perinatal inflammation in extremely premature infants.
Official title: Advancing IL-1Ra to Prevent Inflammatory Disease in Preterm Infants - Pilot
Key Details
Gender
All
Age Range
24 Weeks - 28 Weeks
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2022-02-15
Completion Date
2025-03
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Interventions
DRUG
Anakinra
Anakinra will be given to enrolled infants starting in the first 24hrs of life for the first 3 weeks of life.
Locations (2)
Monash Health
Clayton, Victoria, Australia
Starship Children's Hospital, Te Whatu Ora - Health New Zealand
Grafton, Auckland, New Zealand